Key facts
- It has raised $1.1M across 2 recorded rounds; the latest was Seed Round ($410K) in Mar 2025.
- Slipstream Solutions has filed 2 Form Ds with the SEC since 2023, most recently Mar 2025 ($410K sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Slipstream Solutions
Funding rounds
2 roundsAbout Slipstream Solutions
Developer of medical technology devices designed to treat fluid stasis-related conditions such as swelling, inflammation, and pain. The company develops contactless fluid clearance therapy systems that use directed energy or airflow mechanisms to mobilize and transport bodily fluids through lymphatic and venous pathways, support clinician-controlled treatment customization, and enable non-invasive therapy delivery, enabling healthcare providers to manage edema, improve recovery, and reduce patient discomfort.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2022
- Website
- slipstreamrx.com/
- Ownership
- Privately Held (backing)
Slipstream Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Slipstream Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Slipstream Solutions in its N-PORT filings yet. We sweep new filings monthly.